Literature DB >> 20725907

Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.

Ajay Duseja, Balkrishan Sharma, Amit Kumar, Shweta Kapil, Ashim Das, Radha K Dhiman, Yogesh K Chawla.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20725907     DOI： 10.1002/hep.23838

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  25 in total

Review 1.  Hepatology in India and INASL: A Ringside View.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 2.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

3.  Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.

Authors:  Amit Kumar; Arun Sharma; Ajay Duseja; Ashim Das; Radha K Dhiman; Yogesh K Chawla; Krishan K Kohli; Anil Bhansali
Journal:  J Clin Exp Hepatol       Date:  2012-11-02

Review 4.  The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Vivek A Saraswat; Anil Arora; Ajay Duseja; Mahesh K Goenka; Deepali Jain; Premashish Kar; Manoj Kumar; Vinay Kumaran; Kunisshery M Mohandas; Dipanjan Panda; Shashi B Paul; Jeyamani Ramachandran; Hariharan Ramesh; Padaki N Rao; Samir R Shah; Hanish Sharma; Ragesh B Thandassery
Journal:  J Clin Exp Hepatol       Date:  2014-05-22

Review 5.  Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Authors:  Ajay Duseja; Shivaram P Singh; Vivek A Saraswat; Subrat K Acharya; Yogesh K Chawla; Subhankar Chowdhury; Radha K Dhiman; Rohinivilasam V Jayakumar; Kaushal Madan; Sri P Misra; Hrudananda Mishra; Sunil K Modi; Arumugam Muruganathan; Banshi Saboo; Rakesh Sahay; Rajesh Upadhyay
Journal:  J Clin Exp Hepatol       Date:  2015-03-06

Review 6.  Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Authors:  Ajay Duseja
Journal:  Indian J Gastroenterol       Date:  2010-12-30

Review 7.  Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Authors:  Narendra S Choudhary; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

8.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).

Authors:  Ajay Duseja; Naga Chalasani
Journal:  Hepatol Int       Date:  2013-11-02       Impact factor: 6.047

9.  Non-alcoholic Fatty Liver Disease: East Versus West.

Authors:  Swastik Agrawal; Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 10.  Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.